Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports

Christian R. Klein,Annkristin Heine,Peter Brossart,Pantelis Karakostas,Valentin Sebastian Schäfer
DOI: https://doi.org/10.1007/s00296-024-05683-5
2024-09-14
Rheumatology International
Abstract:Since the introduction of mRNA vaccines against SARS-CoV-2, the induction of autoimmunity by mRNA vaccination has been discussed. Several cases of dermatomyositis (DM) associated with mRNA vaccination against SARS-CoV-2 infection have been reported. The question is whether there is a common pathomechanism for the induction of DM by this mRNA vaccination. The aim of this review is to analyse the sample of previously published case reports of DM following COVID-19 mRNA vaccination for common indicators of a possible immune pathomechanism.
rheumatology
What problem does this paper attempt to address?